Table 3.
Percentage of child-days with low bioavailability* of zinc by site and age period
| Site | Age (months) | |||||||
|---|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | n | % | |
| 9–12 | 13–16 | 17–20 | 21–24 | |||||
| South Asia | ||||||||
| BGD | 72 | 7·3 | 65 | 6·7 | 90 | 9·8 | 88 | 9·8 |
| INV | 492 | 49·9 | 358 | 37·4 | 329 | 33·6 | 399 | 39·1 |
| PKN | 64 | 5·9 | 64 | 5·9 | 59 | 5·5 | 88 | 8·3 |
| Latin America | ||||||||
| BRF | 8 | 1·0 | 0 | 0·0 | 0 | 0·0 | 0 | 0·0 |
| PEL | 223 | 21·8 | 114 | 12·0 | 66 | 7·5 | 61 | 7·5 |
| Sub-Saharan Africa | ||||||||
| SAV | 837 | 84·5 | 847 | 83·3 | 851 | 84·1 | 811 | 80·7 |
| TZH | 913 | 95·5 | 950 | 97·8 | 962 | 100·0 | 889 | 100·0 |
BGD, Dhaka, Bangladesh; BRF, Fortaleza, Brazil; INV, Vellore, India; PEL, Loreto, Peru; PKN, Naushero Feroze, Pakistan; SAV, Venda, South Africa; TZH, Haydom, Tanzania.
*
Low bioavailability was identified based on phytate-to-zinc ratio >15. Ref. (23).